glutamic acid has been researched along with Acute Relapsing Multiple Sclerosis in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (42.86) | 29.6817 |
2010's | 5 (35.71) | 24.3611 |
2020's | 3 (21.43) | 2.80 |
Authors | Studies |
---|---|
Bellantonio, P; Buttari, F; Casamassa, A; Centonze, D; De Rosa, A; Di Maio, A; Errico, F; Fantozzi, R; Finardi, A; Furlan, R; Galifi, G; Gilio, L; Miroballo, M; Nuzzo, T; Stampanoni Bassi, M; Usiello, A | 1 |
Castañares, C; Cristiano, E; Lopez, PH; Pappolla, A; Patrucco, L; Rojas, JI; Sánchez, F; Varela, L | 1 |
C, B; C, F; Cp, Z; G, C; G, DC; M, C; M, F; M, G; M, R; M, S; R, F; S, A | 1 |
Barkhof, F; Eijlers, AJ; Geurts, JJ; Klauser, AM; Pouwels, PJ; Schoonheim, MM; Uitdehaag, BM; Wiebenga, OT | 1 |
Cao, G; Edden, RAE; Evans, AC; Gao, F; Li, H; Li, M; Wang, G; Wang, J; Xu, J; Yin, X; Zhao, B | 1 |
Atzori, M; Ciccarelli, O; De Vita, E; Geurts, JJ; Miller, DH; Muhlert, N; Samson, RS; Thomas, DL; Thompson, AJ; Wheeler-Kingshott, CA | 1 |
Falato, E; Filippi, MM; Ghazaryan, A; Landi, D; Mulas, D; Pasqualetti, P; Pellegrino, G; Rossini, PM; Vollaro, S | 1 |
Baranovičová, E; Bittšanský, M; Čierny, D; Hnilicová, P; Kantorová, E; Kurča, E; Nosáľ, V; Poláček, H; Sivák, Š; Zeleňák, K | 1 |
Westall, FC | 1 |
Green, AJ | 1 |
Altmann, DR; Chard, DT; Davies, G; Griffin, CM; McLean, MA; Miller, DH; Rashid, W; Sastre-Garriga, J; Thompson, AJ; Tiberio, M | 1 |
Domercq, M; Matute, C; Pampliega, O; Rodríguez-Antigüedad, A; Sepulcre, J; Villoslada, P | 1 |
Helms, G | 1 |
Bisaga, GN; Odinak, MM; Pozdniakov, AV; Tiutin, LA | 1 |
14 other study(ies) available for glutamic acid and Acute Relapsing Multiple Sclerosis
Article | Year |
---|---|
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
Topics: Adult; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Glutamic Acid; Humans; Inflammation Mediators; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neurodegenerative Diseases; Oxidative Stress | 2021 |
[Prognostic value of cerebrospinal fluid glutamate in multiple sclerosis].
Topics: Glutamic Acid; Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Prognosis | 2021 |
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis.
Topics: Adult; Blood Platelets; Female; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Inflammation; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Th1 Cells | 2020 |
Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.
Topics: Adult; Brain; Choline; Diffusion Tensor Imaging; Female; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Young Adult | 2018 |
Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis.
Topics: Adult; Brain Mapping; Cognition; Female; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Relapsing-Remitting; Neural Pathways; Neuropsychological Tests; Rest | 2018 |
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Brain Chemistry; Cognition; Female; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Learning; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neuroimaging; Neuropsychological Tests | 2014 |
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
Topics: Administration, Oral; Adult; Animals; Evoked Potentials, Motor; Female; Fingolimod Hydrochloride; Glutamic Acid; Humans; Immunosuppressive Agents; Male; Middle Aged; Motor Cortex; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Prospective Studies; Sphingosine; Transcranial Magnetic Stimulation | 2015 |
Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.
Topics: Adult; Aging; Aspartic Acid; Case-Control Studies; Choline; Creatine; Cross-Sectional Studies; Depression; Disability Evaluation; Fatigue; Female; Glutamic Acid; Humans; Hypothalamus; Inositol; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Severity of Illness Index | 2017 |
A response to "Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis".
Topics: Excitatory Amino Acid Transporter 2; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Multiple Sclerosis, Relapsing-Remitting; Polymorphism, Genetic | 2008 |
Understanding pseudo: the symptoms are real, the cause is unclear.
Topics: Brain; Chemotaxis, Leukocyte; Clinical Trials as Topic; Encephalitis; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Iatrogenic Disease; Inflammation Mediators; Memantine; Multiple Sclerosis, Relapsing-Remitting; Nystagmus, Pathologic; Secondary Prevention | 2009 |
Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
Topics: Adult; Aspartic Acid; Choline; Creatine; Dipeptides; Female; Follow-Up Studies; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Statistics, Nonparametric; Time Factors | 2006 |
Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.
Topics: Adult; Aged; Cell Line, Transformed; Excitatory Amino Acid Transporter 2; Female; Gene Frequency; Genotype; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Male; Middle Aged; Monocytes; Multiple Sclerosis, Relapsing-Remitting; Polymorphism, Genetic; T-Lymphocytes | 2008 |
Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions.
Topics: Adult; Aspartic Acid; Brain; Case-Control Studies; Choline; Contrast Media; Creatine; Edema; Female; Gadolinium DTPA; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Regression Analysis; Signal Processing, Computer-Assisted | 2001 |
[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Creatine; Demyelinating Diseases; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Phosphocreatine; Severity of Illness Index | 2001 |